Table 1.

Cumulative number of events for overall, progression-free, and distant metastasis-free survival at 2, 5, and 10 years

End point	2 years No. (%)	5 years No. (%)	10 years No. (%)	Total No. (%)
Overall survival	837 (38.7)	1658 (76.7)	2039 (94.3)	2162 (100.0)
Control arm	468 (40.6)	897 (77.7)	1099 (95.2)	1154 (100.0)
Chemotherapy arm	369 (36.6)	761 (75.5)	940 (93.3)	1008 (100.0)
Progression-free survival	1613 (62.0)	2224 (85.5)	2501 (96.2)	2600 (100.0)
Control arm	907 (65.2)	1206 (86.6)	1350 (97.0)	1392 (100.0)
Chemotherapy arm	706 (58.4)	1018 (84.3)	1151 (95.3)	1208 (100.0)
Distant metastasis–free survival	1270 (54.4)	1891 (81.1)	2218 (95.1)	2333 (100.0)
Control arm	716 (57.0)	1026 (81.7)	1205 (95.9)	1256 (100.0)
Chemotherapy arm	554 (51.4)	865 (80.3)	1013 (94.1)	1077 (100.0)